What is NDC 65219-368?

65219-368 is the product NDC for Lorazepam, Lorazepam 2 mg/mL injection, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 65219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lorazepam?

134 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lorazepam NDC 65219-368 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65219-368Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65219-0368Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65219-368-02	65219036802	25 VIAL in 1 TRAY (65219-368-02) / 1 mL in 1 VIAL (65219-368-01)Marketed from Dec 13, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lorazepam
Generic name (nonproprietary): lorazepam
Active ingredients: Lorazepam — 2 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 65219
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217598
Marketing start: Dec 13, 2024
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)
Identifiers: Product ID 65219-368_5cd2d0d8-9639-4e96-aafd-4991ad35fabcSPL ID 5cd2d0d8-9639-4e96-aafd-4991ad35fabcSPL set ID b2487467-a63f-48b5-b0de-3a6ce6672d50RxCUI 1665188UNII O26FZP769LUPC 0365219368014
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219036802 followed by a unit qualifier and the quantity

Package 65219-0368-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 26, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Status Epilepticus Lorazepam Injection is indicated for the treatment of status epilepticus. Preanesthetic Lorazepam Injection is indicated in adult patients for preanesthetic medication, producing sedation (sleepiness or drowsiness), relief of anxiety, and a decreased ability to recall events related to the day of surgery. It is most useful in those patients who are anxious about their surgical procedure and who would prefer to have diminished recall of the events of the day of surgery (see PRECAUTIONS, Information for Patients ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65219-368

What is NDC 65219-368?: 65219-368 is the product NDC for Lorazepam, Lorazepam 2 mg/mL injection, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lorazepam.
What is the active ingredient?: Lorazepam.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 65219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lorazepam?: 134 other product NDCs are listed under this name. See all Lorazepam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lorazepam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lorazepam	Lorazepam 1 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-091	87441-0091-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4180	68788-4180-0168788-4180-0368788-4180-06+2 more
Lorazepam	Lorazepam .5 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-947	60760-0947-02
Lorazepam	Lorazepam 1 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-948	60760-0948-02
Lorazepam	Lorazepam .5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-050	87441-0050-01
Lorazepam	Lorazepam 2 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-051	87441-0051-01
Lorazepam	Lorazepam 1 mg/1	TabletOral	Coupler LLC	67046-0230	67046-0230-03
Lorazepam	Lorazepam .5 mg/1	TabletOral	Coupler LLC	67046-0786	67046-0786-03
Lorazepam	Lorazepam 2 mg/1	TabletOral	Coupler LLC	67046-0936	67046-0936-03
Lorazepam	Lorazepam 2 mg/mL	LiquidOral	American Health Packaging	68000-107	68000-0107-05

All 135 Lorazepam NDCs